Patents by Inventor Sarah A. Gebb

Sarah A. Gebb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of facilitating vascular growth
    Patent number: 6875749
    Abstract: A method of facilitating vascular growth in a subject in need of such treatment comprises inhibiting EMAP II activity in the subject by an amount effective to stimulate vascular growth in the subject (e.g., in the lungs or heart of the subject). Pharmaceutical formulations useful for carrying out such methods (e.g., an antibody that specifically binds to EMAP II in a pharmaceutically acceptable carrier) and screening techniques useful for identifying additional compounds that can be used for carrying out such methods are also disclosed.
    Type: Grant
    Filed: August 13, 2001
    Date of Patent: April 5, 2005
    Assignees: Childrens Hospital Los Angeles, National Jewish Medical and Research Center
    Inventors: Margaret A. Schwarz, Fangrong Zhang, Sarah A. Gebb
  • Methods of facilitating vascular growth
    Publication number: 20020042086
    Abstract: A method of facilitating vascular growth in a subject in need of such treatment comprises inhibiting EMAP II activity in the subject by an amount effective to stimulate vascular growth in the subject (e.g., in the lungs or heart of the subject). Pharmaceutical formulations useful for carrying out such methods (e.g., an antibody that specifically binds to EMAP II in a pharmaceutically acceptable carrier) and screening techniques useful for identifying additional compounds that can be used for carrying out such methods are also disclosed.
    Type: Application
    Filed: August 13, 2001
    Publication date: April 11, 2002
    Inventors: Margaret A. Schwarz, Fangrong Zhang, Sarah A. Gebb
  • Methods of facilitating vascular growth
    Patent number: 6306612
    Abstract: A method of facilitating vascular growth in a subject in need of such treatment comprises inhibiting EMAP II activity in the subject by an amount effective to stimulate vascular growth in the subject (e.g., in the lungs or heart of the subject). Pharmaceutical formulations useful for carrying out such methods (e.g., an antibody that specifically binds to EMAP II in a pharmaceutically acceptable carrier) and screening techniques useful for identifying additional compounds that can be used for carrying out such methods are also disclosed.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: October 23, 2001
    Assignees: Children Hospital Los Angeles, National Jewish Medical and Research Center
    Inventors: Margaret A. Schwarz, Fangrong Zhang, Sarah A. Gebb